Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
IMMUNEBRO THERAPEUTICS INC has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $361,635 in 2024. These are non-dilutive federal research grants, not equity financing. The company is based in CHICAGO, Illinois.
1 round · latest SBIR Phase I award (HHS), May 2024
Sign in to see 1 rounds.
Sign inNo investors recorded yet for IMMUNEBRO THERAPEUTICS INC.
Add an investorIMMUNEBRO THERAPEUTICS INC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for IMMUNEBRO THERAPEUTICS INC.
Add diversity data